DarioHealth Corp. (DRIO)

NASDAQ: DRIO · IEX Real-Time Price · USD
1.740
-0.255 (-12.78%)
At close: Mar 4, 2024, 4:00 PM
1.749
+0.009 (0.52%)
After-hours: Mar 4, 2024, 5:24 PM EST
-12.78%
Market Cap 55.44M
Revenue (ttm) 23.55M
Net Income (ttm) -60.89M
Shares Out 27.21M
EPS (ttm) -2.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153,089
Open 2.030
Previous Close 1.995
Day's Range 1.720 - 2.030
52-Week Range 0.680 - 5.460
Beta 1.69
Analysts Strong Buy
Price Target 6.03 (+246.55%)
Earnings Date Mar 15, 2024

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its user-centric multi-chronic condition digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight man... [Read more]

Sector Healthcare
Founded 2011
Employees 241
Stock Exchange NASDAQ
Ticker Symbol DRIO
Full Company Profile

Financial Performance

In 2022, DarioHealth's revenue was $27.66 million, an increase of 34.82% compared to the previous year's $20.51 million. Losses were -$63.84 million, -18.95% less than in 2021.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price forecast is $6.03, which is an increase of 246.55% from the latest price.

Price Target
$6.03
(246.55% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE

NEW YORK, Feb. 28, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen 44th Annual Health...

5 days ago - PRNewsWire

Today's Schedule at The MicroCap Rodeo Winter Wrap Up Conference

Six Top MicroCap CEOs To Watch Live RALEIGH, NC / ACCESSWIRE / February 21, 2024 / On the second day of our virtual conference, the CEOs of the following companies will present: 10:00 AM EST La Rosa H...

Other symbols: DTSTJNVRLRHCSPGC
12 days ago - Accesswire

Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions

Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross margins and expected to accelerate path to profitability Concurrent with the acqu...

12 days ago - PRNewsWire

Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support

Dario's integrated solution to support improved whole health gains traction in public and labor market NEW YORK , Jan. 11, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Compan...

7 weeks ago - PRNewsWire

National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health

New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication NEW YORK , Dec. ...

3 months ago - PRNewsWire

Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering

Nonprofit health plan expands services to better meet the healthcare needs of Californians by making it easier to enroll in lifestyle medicine programs at no additional cost OAKLAND, Calif. , Nov. 29,...

3 months ago - PRNewsWire

Dario Contracts with New Employer for Cardiometabolic Solution

Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YOR...

3 months ago - PRNewsWire

New Research Sheds Light on Mediators of Improved Outcomes in Dario Users

Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the...

3 months ago - PRNewsWire

Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose

New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW YORK , Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Da...

4 months ago - PRNewsWire

DarioHealth Reports Third Quarter 2023 Financial and Operating Results

Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of $209,000 as compar...

4 months ago - PRNewsWire

Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter

New connectivity expands Dario's advantage with consumer accessibility NEW YORK , Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digit...

4 months ago - PRNewsWire

DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd

Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 30, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that i...

4 months ago - PRNewsWire

New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes

New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ribbon award NEW YORK , Oct. 17, 2023 /PRNe...

4 months ago - PRNewsWire

Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm

Agreement names Dario as the preferred digital health provider for employer clients NEW YORK , Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the...

5 months ago - PRNewsWire

DarioHealth to Host Investor Day on The Rise of Digital Health

In-person event scheduled for Tuesday, October 17, 2023, in New York NEW YORK , Oct. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital...

5 months ago - PRNewsWire

Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs

63% of members using the Dario platform saw significant reduction in depression and anxiety symptoms NEW YORK , Sept. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company...

5 months ago - PRNewsWire

Dario Publishes New Research Demonstrating Greater Engagemenet and Improved Clinical Outcomes Sustainable for Two Years

New research presented at ADCES23 links engagement in Dario's digital health solutions with improved outcomes NEW YORK , Aug. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the ...

6 months ago - PRNewsWire

Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions

New agreement expands Dario's reach in the employer market with access to more than 5 million consumers NEW YORK , Aug. 15, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Compa...

7 months ago - PRNewsWire

DarioHealth Reports Second Quarter 2023 Financial and Operating Results

- Generated sequential B2B recurring revenue growth for the tenth consecutive quarter - Revenues of $6.15 million (pre-announced), compared to $6.18 million in the second quarter of 2022, a 0.5% decre...

7 months ago - PRNewsWire

Dario Expands Partnership with Large Regional Health Plan

Dario to provide support for members living with diabetes alongside existing hypertension solution NEW YORK , Aug. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), ...

7 months ago - PRNewsWire

DarioHealth to Report Second Quarter 2023 Results on Thursday, August 10th

Company to host conference call and webcast at 8:30am ET NEW YORK , Aug. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health  market, today announced that i...

7 months ago - PRNewsWire

Dario Introduces GLP-1 Behavior Change Program to Help Achieve Weight Loss Goals and Better Overall Health Outcomes

New program delivers whole health behavior change program to improve member health and deliver valuable insights to Dario's partners NEW YORK , Aug. 2, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: ...

7 months ago - PRNewsWire

New Research Shows $5,077 in Medical Costs Savings for Dario Users

Retrospective cohort study demonstrated significant reduction in medical costs for Dario users with Type 2 diabetes compared to non-users driven by a significant reduction in in-patient hospitalizatio...

7 months ago - PRNewsWire

Dario Launches Agreement with Large Regional Health Plan and Announces Preliminary Results for Second Quarter of 2023 as well as Business Update

New account is set to launch in July 2023 for eligible members NEW YORK , July 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital heal...

8 months ago - PRNewsWire

Dario Announces New Full Suite Employer Contract

New account anticipated to contribute to revenue in the second half of 2023 NEW YORK , July 6, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global ...

8 months ago - PRNewsWire